Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Stanford Partners With Singapore On Device Design Training Program

This article was originally published in PharmAsia News

Executive Summary

Stanford University's respected medical technology design program is putting its bets on Singapore as a portal into the rapidly growing Asian device market

You may also be interested in...



Singapore, UK Award Infectious Disease Research Grants As Singapore Continues To Build Biomedical Research Base

SINGAPORE - Singapore and the United Kingdom have awarded SGD$4.5 million ($3.2 million) in grants covering six infectious disease research projects conducted jointly by Singapore and UK universities. The diseases include gastric flu, hepatitis B, dengue fever and tuberculosis

Singapore, UK Award Infectious Disease Research Grants As Singapore Continues To Build Biomedical Research Base

SINGAPORE - Singapore and the United Kingdom have awarded SGD$4.5 million ($3.2 million) in grants covering six infectious disease research projects conducted jointly by Singapore and UK universities. The diseases include gastric flu, hepatitis B, dengue fever and tuberculosis

Singapore Gains Momentum As Major R&D, Manufacturing Hub; Sees Double-digit Pharma Sector Growth

SHANGHAI - Output of Singapore's biomedical manufacturing cluster increased 14.8 percent last year, according to Singapore's Economic Development Board. Within the cluster, the pharmaceuticals segment grew 15.6 percent with higher levels of production of active pharmaceutical ingredients. Output of the medical technology segment edged up 0.8 percent to meet export orders for surgical and medical instruments

Latest Headlines
See All
UsernamePublicRestriction

Register

SC074034

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel